Failure to Notify Medical Director and Delay in Diagnostic Testing
Summary
The facility failed to notify the Medical Director of a resident's documented allergy to aspirin and the family's concern about the lack of anticoagulation therapy following a fall that resulted in multiple fractures. The resident, who had a history of gastrointestinal bleeding, was discharged from the hospital without an anticoagulant prescription despite receiving subcutaneous heparin injections during the hospital stay. The resident's Responsible Party (RP) expressed concerns to the Director of Nursing (DON) about the absence of anticoagulation therapy, but the facility did not take appropriate action to address these concerns. On 12/11/2024, the Assistant Director of Nursing (ADON) was informed by the Nurse Practitioner (NP) to contact the Medical Director for further direction regarding anticoagulation, but this was not done. The NP initially ordered aspirin, which was later discontinued due to the resident's allergy. The resident experienced increased pain and swelling in the left lower extremity, indicative of a potential deep vein thrombosis (DVT), but the facility failed to notify the NP that a venous doppler study could not be completed until the following week. This delay in communication and action resulted in the resident being transferred to the Emergency Department (ED) on 12/28/2024, where extensive DVT was diagnosed. Interviews with facility staff revealed a lack of communication and follow-up regarding the resident's condition and the necessary medical interventions. The Medical Director was not informed of the resident's condition or the delay in diagnostic testing, which could have prompted earlier intervention. The NP was also not made aware of the delay in the venous doppler study, which could have influenced the decision to send the resident to the ED sooner. This series of inactions and communication failures contributed to the deficiency identified in the facility's care of the resident.
Removal Plan
- All licensed nurses, medication aides, and certified nursing assistants were educated by the Director of Nursing (DON) and the Assistant Director of Nursing (ADON) on requirement to notify physician of all significant changes in condition to ensure timely treatment or transfers.
- Licensed nurses, medication aides and certified nursing assessments who are newly hired, including agency, will receive in-service prior to working their initial shift.
- Director of Nursing and/or Staff Development coordinator will be responsible to ensure education is received.
- Ordered studies should be scheduled same day of order.
- If vendor is unable to perform study on same day of order, provider is to be notified by licensed nurse of expected date of study.
- New orders from medical providers given to address changes in condition should be implemented on day of order, unless otherwise noted by provider. If orders are unable to be implemented timely, provider must be made aware immediately in order to ensure any new intervention or transfer is then implemented timely.
- Licensed nurse is to document notification and any new orders, to include transfer to hospital, deemed necessary by medical provider.
- Physician or physician extender is to be made aware by licensed nurse of all residents with aspirin allergy to determine any needs for anticoagulation. This notification to occur upon admission or readmission with any newly identified aspirin allergy.
- Certified nursing assistants and medication aides who identify changes in condition should notify licensed nurse.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



